ONS CHEMOTHERAPY IMMUNOTHERAPY CERTIFICATE
EXAM QUESTION WITH CORRECT ANSWERS RATED A+
3TmajorTphasesTofTcellTdivision:T-TCORRECTTANSWERSInterphase
MitoticTphase
Cytokinesis
3TstepsTofTinterphase:T-TCORRECTTANSWERSFirstTgrowthTphaseT(G1)
SynthesisTphaseT(STphase)
SecondTgrowthTphaseT(G2)
4TphasesTofTmitosis:T-TCORRECTTANSWERSProphase
Metaphase
Anaphase
Telophase
InnateTimmunity:T-TCORRECTTANSWERSNon-specificTresponse,Teither:
1.TBarrierT(skin,TmucousTmembranes,TfloraTofTskin/gut)
2.TCellularTcomponentsT(phagocytes,TnaturalTkillerTcells,Tgranulocytes,Tmacrophages)
AdaptiveTimmunity:T-
TCORRECTTANSWERSFollowsTinnateTimmunityTifTunsuccessful.TMemoryTimmunity,Tincluding:
1.THumoralTimmunityT(productionTofTantibodiesTorTimmunoglobulins)
2.TCellTmediatedTimmunityT(dependentTuponTTTcells)
3.TRegulatoryTTT-cellsT(preventTautoimmuneTreactionsTandTlimitTinflammatoryTresponses)
DefineTmutationsT-TCORRECTTANSWERSVariationsTinTtheTnucleotideTsequenceTofTaTgene
,3TmainTgoalsTofTtreatment:T-TCORRECTTANSWERSCure
Control
Palliation
DefineTneoadjuvantTtherapyT-
TCORRECTTANSWERSTreatmentTisTgivenTpriorTtoTsurgeryTtoTshrinkTtheTtumor
DefineTadjuvantTtherapyT-
TCORRECTTANSWERSAdditionalTcancerTtreatmentTgivenTafterTtheTprimaryTtreatmentTtoTlowerTtheT
riskTthatTtheTcancerTreoccur
DefineTconditioning/preparativeTtherapyT-
TCORRECTTANSWERSTreatmentsTusedTtoTprepareTaTpatientTforTstemTcellTtransplantation
2TtypesTofTconditioningTtherapies:T-TCORRECTTANSWERSMyeloablative
Nonmyeloablative
DefineTdoseTdensityT-TCORRECTTANSWERSDrugTdoseTperTunitTofTtime
DefineTdoseTintensityT-TCORRECTTANSWERSAmountTofTdrugTdeliveredToverTtime
HowTisTrelativeTdoseTintensityT(RDI)Tcalculated?T-
TCORRECTTANSWERSByTcomparingTtheTdoseTthatTtheTpatientTACTUALLYTreceivedTtoTtheTplannedTd
oseTofTtheTstandardTregimen
, HowTdoTalkylatingTagentsTwork?T-
TCORRECTTANSWERSByTcausingTaTbreakTinTtheTDNAThelixTstrand,TinterferingTwithTDNATreplicationT
andTcausingTcellTdeath
3TsubcategoriesTofTalkylatingTagents:T-TCORRECTTANSWERS1.TNitrogenTmustards
2.TPlatinum-
basedTagentsT(doTnotTpossessTanTalkylTgroupTbutTstillTtermedTalkylatingTagentsTasTtheyTworkTsimila
rly)
3.TNitrosoureas
MostTcommonTsubcategoryTofTalkylatingTagents:T-TCORRECTTANSWERSNitrogenTmustards
CommonTalkylatingTagents:T-TCORRECTTANSWERSCyclophosphamideT(Cytoxan)
IfosfamideT(Ifex)
BendamustineT(Treanda)
CommonTplatinum-basedTagents:T-TCORRECTTANSWERSCisplatinT(Platinol)
CarboplatinT(Paraplatin)
WhatTisTuniqueTaboutTnitrosoureasTagents?T-TCORRECTTANSWERSAbleTtoTcrossTtheTblood-
brainTbarrier;TcanTbeTeffectiveTinTtreatingTsomeTbrainTtumors
CommonTnitrosoureasTagents:T-TCORRECTTANSWERSCarmustineT(BiCNU)
LomustineT(CeeNu)
StreptozocinT(Zanosar)
HypersensitivityTcanToccurTwithTlateTdosesTof:T-TCORRECTTANSWERSCarboplatin
EXAM QUESTION WITH CORRECT ANSWERS RATED A+
3TmajorTphasesTofTcellTdivision:T-TCORRECTTANSWERSInterphase
MitoticTphase
Cytokinesis
3TstepsTofTinterphase:T-TCORRECTTANSWERSFirstTgrowthTphaseT(G1)
SynthesisTphaseT(STphase)
SecondTgrowthTphaseT(G2)
4TphasesTofTmitosis:T-TCORRECTTANSWERSProphase
Metaphase
Anaphase
Telophase
InnateTimmunity:T-TCORRECTTANSWERSNon-specificTresponse,Teither:
1.TBarrierT(skin,TmucousTmembranes,TfloraTofTskin/gut)
2.TCellularTcomponentsT(phagocytes,TnaturalTkillerTcells,Tgranulocytes,Tmacrophages)
AdaptiveTimmunity:T-
TCORRECTTANSWERSFollowsTinnateTimmunityTifTunsuccessful.TMemoryTimmunity,Tincluding:
1.THumoralTimmunityT(productionTofTantibodiesTorTimmunoglobulins)
2.TCellTmediatedTimmunityT(dependentTuponTTTcells)
3.TRegulatoryTTT-cellsT(preventTautoimmuneTreactionsTandTlimitTinflammatoryTresponses)
DefineTmutationsT-TCORRECTTANSWERSVariationsTinTtheTnucleotideTsequenceTofTaTgene
,3TmainTgoalsTofTtreatment:T-TCORRECTTANSWERSCure
Control
Palliation
DefineTneoadjuvantTtherapyT-
TCORRECTTANSWERSTreatmentTisTgivenTpriorTtoTsurgeryTtoTshrinkTtheTtumor
DefineTadjuvantTtherapyT-
TCORRECTTANSWERSAdditionalTcancerTtreatmentTgivenTafterTtheTprimaryTtreatmentTtoTlowerTtheT
riskTthatTtheTcancerTreoccur
DefineTconditioning/preparativeTtherapyT-
TCORRECTTANSWERSTreatmentsTusedTtoTprepareTaTpatientTforTstemTcellTtransplantation
2TtypesTofTconditioningTtherapies:T-TCORRECTTANSWERSMyeloablative
Nonmyeloablative
DefineTdoseTdensityT-TCORRECTTANSWERSDrugTdoseTperTunitTofTtime
DefineTdoseTintensityT-TCORRECTTANSWERSAmountTofTdrugTdeliveredToverTtime
HowTisTrelativeTdoseTintensityT(RDI)Tcalculated?T-
TCORRECTTANSWERSByTcomparingTtheTdoseTthatTtheTpatientTACTUALLYTreceivedTtoTtheTplannedTd
oseTofTtheTstandardTregimen
, HowTdoTalkylatingTagentsTwork?T-
TCORRECTTANSWERSByTcausingTaTbreakTinTtheTDNAThelixTstrand,TinterferingTwithTDNATreplicationT
andTcausingTcellTdeath
3TsubcategoriesTofTalkylatingTagents:T-TCORRECTTANSWERS1.TNitrogenTmustards
2.TPlatinum-
basedTagentsT(doTnotTpossessTanTalkylTgroupTbutTstillTtermedTalkylatingTagentsTasTtheyTworkTsimila
rly)
3.TNitrosoureas
MostTcommonTsubcategoryTofTalkylatingTagents:T-TCORRECTTANSWERSNitrogenTmustards
CommonTalkylatingTagents:T-TCORRECTTANSWERSCyclophosphamideT(Cytoxan)
IfosfamideT(Ifex)
BendamustineT(Treanda)
CommonTplatinum-basedTagents:T-TCORRECTTANSWERSCisplatinT(Platinol)
CarboplatinT(Paraplatin)
WhatTisTuniqueTaboutTnitrosoureasTagents?T-TCORRECTTANSWERSAbleTtoTcrossTtheTblood-
brainTbarrier;TcanTbeTeffectiveTinTtreatingTsomeTbrainTtumors
CommonTnitrosoureasTagents:T-TCORRECTTANSWERSCarmustineT(BiCNU)
LomustineT(CeeNu)
StreptozocinT(Zanosar)
HypersensitivityTcanToccurTwithTlateTdosesTof:T-TCORRECTTANSWERSCarboplatin